An approach to tailor the morphology and sensing characteristics of CuO nanoplatelets for selective detection of NO2 gas is of great significance and an important step toward achieving the challenge of improving air quality and in assuring the safety of mining operations. As a result, in this study, we report on the NO2 room temperature gas-sensing characteristics of CuO nanoplatelets and the underlying mechanism toward the gas-sensing performance by altering the synthesis reaction base and time. High sensitivity of ∼40 ppm–1 to NO2 gas at room temperature has been realized for gas sensors fabricated from CuO nanoplatelets, using NaOH as base for reaction times of 45 and 60 min, respectively at 75 °C. In both cases, the crystallite size, surface area, and hole concentration of the respective materials influenced the selectivity and sensitivity of the NO2 gas sensors. The mechanism underpinning the superior NO2 gas sensing are thoroughly discussed in terms of the crystallite size, hole concentration, and surface area as active sites for gas adsorption.
Non-invasive breath analysis with mobile health devices bears tremendous potential to guide therapeutic treatment and personalize lifestyle changes. Of particular interest is the breath volatile acetone, a biomarker for fat burning, that could help in understanding and treating metabolic diseases. Here, we report a hand-held (6 × 10 × 19.5 cm3), light-weight (490 g), and simple device for rapid acetone detection in breath. It comprises a tailor-made end-tidal breath sampling unit, connected to a sensor and a pump for on-demand breath sampling, all operated using a Raspberry Pi microcontroller connected with a HDMI touchscreen. Accurate acetone detection is enabled by introducing a catalytic filter and a separation column, which remove and separate undesired interferents from acetone upstream of the sensor. This way, acetone is detected selectively even in complex gas mixtures containing highly concentrated interferents. This device accurately tracks breath acetone concentrations in the exhaled breath of five volunteers during a ketogenic diet, being as high as 26.3 ppm. Most importantly, it can differentiate small acetone changes during a baseline visit as well as before and after an exercise stimulus, being as low as 0.5 ppm. It is stable for at least four months (122 days), and features excellent bias and precision of 0.03 and 0.6 ppm at concentrations below 5 ppm, as validated by proton-transfer-reaction time-of-flight mass spectrometry (PTR-ToF-MS). Hence, this detector is highly promising for simple-in-use, non-invasive, and routine monitoring of acetone to guide therapeutic treatment and track lifestyle changes.